Simplex Molecular Ltd
- Active
- Small
- 1 year
- 1m-15m
- Real address
- 3 directors
- 1 owner
- Solo founder
- Manchester
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Summary
Simplex Molecular Ltd is a private limited company registered in England/Wales with the registration number 15924012. The company was founded one year ago on August 29, 2024, and registered at M4 5JW, England, Manchester, 20 Swan Street, First Floor, Swan Buildings. The address is probably real as only nine companies are registered at the same address. Its status is active. The company operates in the processing & manufacturing, the professional services, the pharma, the geospatial services, the biotechnology r&d, the scientific and technical r&d, the basic pharma industries. Officially, it has one owner or PSCs, three directors and no number of employees published.
It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Owners & PSC
-
Individual
- 1 year
- 75%+
-
Resident of United Kingdom
Managers
-
Individual
- 8 months
- 1
-
Resident of United Kingdom
-
Individual
- 1 year
- 4
-
Resident of United Kingdom
-
Individual
- 1 year
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted eight months ago.
Last news
-
Total exemption full accounts made up to 2025-08-31Download 6 pages pdf report
-
Appointment of Dr Parsa Pirhady as a director on 2025-10-01Download 2 pages pdf report
-
Confirmation statement made on 2025-08-28 with no updatesDownload 3 pages pdf report
FAQ about Simplex Molecular Ltd
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.